marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2025-Q2
added 08-13-2025
Aptose Biosciences Shares 2011-2025 | APTO
Annual Shares Aptose Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 699 K | 225 K | 6.15 M | 89.1 M | 81.8 M | 50.2 M | 33.4 M | 22.3 M | - | 11.9 M | 5.22 M | 3.52 M | 1.69 M | 1.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 89.1 M | 225 K | 23.6 M |
Quarterly Shares Aptose Biosciences
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.55 M | 2.13 M | 2.01 M | 558 K | 438 K | 7.94 M | 6.5 M | 6.23 M | 6.17 M | 6.16 M | 6.15 M | 6.15 M | 92.2 M | 92.2 M | 88.9 M | 88.9 M | 88.9 M | 88.9 M | 85.9 M | 76.3 M | 76.2 M | 76.1 M | 55.5 M | 46.5 M | 39.8 M | 38.2 M | 34.6 M | 34 M | 29 M | 27.5 M | 24.1 M | 21.3 M | 17.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.2 M | 438 K | 38.6 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cellectis S.A.
CLLS
|
44.8 M | $ 4.3 | 12.57 % | $ 116 M |  France |
 |
Graybug Vision
GRAY
|
4.49 M | $ 0.44 | -11.23 % | $ 9.65 M |  USA |
 |
AgeX Therapeutics
AGE
|
1.08 K | $ 11.3 | -10.17 % | $ 12.2 K | - |
 |
Galera Therapeutics
GRTX
|
54.6 M | $ 0.14 | -32.59 % | $ 7.61 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
2.52 M | $ 2.52 | -1.18 % | $ 6.35 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
38.2 M | $ 4.37 | -1.58 % | $ 28.1 M |  China |
 |
Caladrius Biosciences
CLBS
|
8.33 M | $ 0.43 | -16.75 % | $ 25.8 M | USA |
 |
Sorrento Therapeutics
SRNE
|
295 M | $ 0.27 | -29.58 % | $ 126 M | USA |
 |
BeiGene, Ltd.
BGNE
|
1.37 B | $ 184.71 | 0.49 % | $ 251 B |  Cayman-islands |
 |
Midatech Pharma plc
MTP
|
80.5 M | $ 0.29 | -18.52 % | $ 27.3 M |  Britain |
 |
Aeterna Zentaris
AEZS
|
115 M | $ 5.72 | 5.93 % | $ 314 M |  Canada |
 |
ContraFect Corporation
CFRX
|
521 K | $ 1.47 | -5.16 % | $ 5.39 M | USA |
 |
Orchard Therapeutics plc
ORTX
|
128 M | $ 4.93 | 1.02 % | $ 90.8 M | Britain |
 |
Advaxis
ADXS
|
6.02 M | $ 0.31 | -9.65 % | $ 45.9 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
4.75 M | $ 3.93 | -5.76 % | $ 99.8 M | USA |
 |
La Jolla Pharmaceutical Company
LJPC
|
27.4 M | $ 6.2 | - | $ 154 M | USA |
 |
Zymeworks
ZYME
|
51.6 M | $ 6.42 | - | $ 404 M | Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
21.6 M | $ 10.5 | - | $ 231 M | USA |
 |
Kadmon Holdings, Inc.
KDMN
|
169 M | $ 9.5 | - | $ 1.7 B | USA |
 |
BioDelivery Sciences International
BDSI
|
99.3 M | $ 2.58 | -4.8 % | $ 255 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
112 M | $ 0.56 | 7.23 % | $ 2.72 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | $ 0.5 | - | $ 7.46 M |  Israel |
 |
Generation Bio Co.
GBIO
|
64.5 M | $ 6.33 | 1.61 % | $ 408 M | USA |
 |
Kiromic BioPharma
KRBP
|
1.53 M | $ 3.15 | 6.61 % | $ 3.08 M | USA |
 |
Acceleron Pharma Inc.
XLRN
|
56.8 M | $ 179.68 | - | $ 10.9 B | USA |
 |
Albireo Pharma
ALBO
|
19.2 M | $ 44.15 | -0.23 % | $ 916 M | USA |
 |
Stealth BioTherapeutics Corp
MITO
|
682 M | $ 0.32 | - | $ 23.9 M | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
83.8 M | $ 18.44 | - | $ 1.94 B | Canada |
 |
Kaleido Biosciences
KLDO
|
41.9 M | $ 0.29 | -3.69 % | $ 12.4 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
43.3 M | $ 2.19 | - | $ 105 M | USA |
 |
Heron Therapeutics
HRTX
|
152 M | $ 1.35 | 2.27 % | $ 206 M | USA |
 |
ImmuCell Corporation
ICCC
|
8.17 M | $ 6.59 | 2.17 % | $ 53.8 M | USA |
 |
Humanigen
HGEN
|
89.2 M | $ 0.04 | -81.12 % | $ 4.28 M | USA |
 |
Aptinyx
APTX
|
67.7 M | $ 0.06 | -39.0 % | $ 4.57 M | USA |
 |
Tyme Technologies
TYME
|
134 M | $ 0.31 | 8.07 % | $ 54 M | USA |
 |
Keros Therapeutics
KROS
|
37.4 M | $ 15.96 | 1.98 % | $ 598 M | USA |
 |
Forward Pharma A/S
FWP
|
97.8 M | $ 2.64 | -0.75 % | $ 18.7 M |  Danmark |
 |
Krystal Biotech
KRYS
|
28.6 M | $ 187.18 | 2.27 % | $ 5.35 B | USA |
 |
Kymera Therapeutics
KYMR
|
75 M | $ 56.29 | -1.11 % | $ 4.22 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
45 M | $ 0.39 | - | $ 26.5 M | USA |
 |
Celyad Oncology SA
CYAD
|
15.6 M | $ 0.47 | - | $ 12.5 M |  Belgium |
 |
Brickell Biotech
BBI
|
5.39 M | $ 2.11 | -5.38 % | $ 6.06 M | USA |
 |
Genocea Biosciences
GNCA
|
68.6 M | $ 0.05 | -15.0 % | $ 3.04 M | USA |
 |
Codiak BioSciences
CDAK
|
21.8 M | $ 0.06 | -55.98 % | $ 2.15 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
34.4 M | $ 8.37 | - | $ 401 M | USA |
 |
AIkido Pharma
AIKI
|
6.18 M | $ 3.17 | 1.93 % | $ 17.4 M | USA |
 |
Calithera Biosciences
CALA
|
73.9 M | $ 0.37 | -10.95 % | $ 876 K | USA |
 |
Forma Therapeutics Holdings
FMTX
|
47.3 M | $ 20.01 | - | $ 958 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
60.8 M | $ 49.55 | -6.81 % | $ 3.04 B | USA |
 |
Sierra Oncology
SRRA
|
13.3 M | $ 54.89 | -0.05 % | $ 1.34 B | Canada |